Thromboprophylaxis and anticoagulation for inpatients with COVID-19 in 2022 and beyond.
作者信息
Dalager-Pedersen Michael
机构信息
Department of Infectious Diseases, Aalborg University Hospital, Aalborg 9000, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg 9000, Denmark.
出版信息
Clin Microbiol Infect. 2022 Sep;28(9):1184-1186. doi: 10.1016/j.cmi.2022.05.027. Epub 2022 May 29.
Abstract
摘要
相似文献
1
Thromboprophylaxis and anticoagulation for inpatients with COVID-19 in 2022 and beyond.
Clin Microbiol Infect. 2022 Sep;28(9):1184-1186. doi: 10.1016/j.cmi.2022.05.027. Epub 2022 May 29.
2
Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines.
Swiss Med Wkly. 2020 Jun 21;150:w20301. doi: 10.4414/smw.2020.20301. eCollection 2020 Jun 15.
3
In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis.
Thromb Res. 2021 Jul;203:82-84. doi: 10.1016/j.thromres.2021.04.026. Epub 2021 May 1.
4
Thromboprophylaxis strategies to improve the prognosis of COVID-19.
Vascul Pharmacol. 2021 Aug;139:106883. doi: 10.1016/j.vph.2021.106883. Epub 2021 Jun 4.
5
Anticoagulation for COVID-19 Patients: A Bird's-Eye View.
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211039288. doi: 10.1177/10760296211039288.
6
Compression stockings in addition to low-molecular-weight heparin to prevent venous thromboembolism in surgical inpatients requiring pharmacoprophylaxis: the GAPS non-inferiority RCT.
Health Technol Assess. 2020 Dec;24(69):1-80. doi: 10.3310/hta24690.
7
Thrombosis in COVID 2022: An Updated Narrative Review of Current Literature and Inpatient Management.
R I Med J (2013). 2022 Aug 1;105(6):36-40.
8
Do lung cancer patients require routine anticoagulation treatment? A meta-analysis.
J Int Med Res. 2020 Jan;48(1):300060519896919. doi: 10.1177/0300060519896919.
9
Thromboprophylaxis for medical inpatients with coronavirus disease 2019.
Clin Microbiol Infect. 2020 Sep;26(9):1125-1126. doi: 10.1016/j.cmi.2020.05.021. Epub 2020 May 23.
10
Thromboprophylaxis Strategies for Hospitalized Patients With COVID-19.
Chest. 2022 Jul;162(1):e69-e70. doi: 10.1016/j.chest.2022.03.038.
本文引用的文献
1
Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial.
J Clin Med. 2022 Sep 24;11(19):5632. doi: 10.3390/jcm11195632.
2
Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID-19: The Swiss COVID-HEP randomized clinical trial.
Res Pract Thromb Haemost. 2022 May 18;6(4):e12712. doi: 10.1002/rth2.12712. eCollection 2022 May.
3
Incidence of pulmonary embolism in COVID-19 infection in the ED: ancestral, Delta, Omicron variants and vaccines.
Emerg Radiol. 2022 Aug;29(4):625-629. doi: 10.1007/s10140-022-02039-z. Epub 2022 Apr 21.
4
Prophylactic anticoagulation with low molecular weight heparin in COVID-19: cohort studies in Denmark and Sweden.
Clin Microbiol Infect. 2022 Sep;28(9):1291.e1-1291.e5. doi: 10.1016/j.cmi.2022.03.006. Epub 2022 Mar 17.
5
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.
Lancet. 2022 Apr 2;399(10332):1303-1312. doi: 10.1016/S0140-6736(22)00462-7. Epub 2022 Mar 16.
6
Anticoagulants for people hospitalised with COVID-19.
Cochrane Database Syst Rev. 2022 Mar 4;3(3):CD013739. doi: 10.1002/14651858.CD013739.pub2.
7
Updated meta-analysis of randomized controlled trials on the safety and efficacy of different prophylactic anticoagulation dosing regimens in non-critically ill hospitalized patients with COVID-19.
Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):E15-E17. doi: 10.1093/ehjcvp/pvac010.
8
The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters.
Antiviral Res. 2022 Feb;198:105253. doi: 10.1016/j.antiviral.2022.105253. Epub 2022 Jan 21.
9
Enoxaparin for thromboprophylaxis in hospitalized COVID-19 patients: The X-COVID-19 Randomized Trial.
Eur J Clin Invest. 2022 May;52(5):e13735. doi: 10.1111/eci.13735. Epub 2021 Dec 26.
10
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Lancet. 2022 Jan 8;399(10320):143-151. doi: 10.1016/S0140-6736(21)01825-0. Epub 2021 Nov 17.
Zotero 插件